Pentoxi-Mepha 400, Retardtabletten

7680493240140 Pharmacode 7040528 CH-49324 C04AD03 02.04.5.
Pentoxi-Mepha 400, Retardtabletten
Pentoxi-Mepha 400, Retardtabletten
Pentoxi-Mepha 400, Retardtabletten
1 / 3
google

Details

GTIN
7680493240140
Pharmacode
7040528
Product number
4932401
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
pentoxifyllinum 400 mg, povidonum K 90, ammonio methacrylatis copolymerum B, cellulosum microcristallinum, talcum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, E 171, macrogolum 6000, acidi ethacrylici et methylis methacrylatis polymerisatum, pro compresso.

Articles (1)

Pentoxi-Mepha 400, Retardtabletten
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
pentoxifyllinum
400.0 MG Substance Wirkstoff (Principe actif)
povidonum K 90
- Substance HNIDK
ammonio methacrylatis copolymerum B
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 6000
- Substance HNIDK
ethylis acrylatis et methylis methacrylatis polymerisatum 2:1
- Substance HNIDK

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
49324
Drug name
Pentoxi-Mepha 400, Retardtabletten
Galenic form
RETT
ATC Code
C04AD03
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
30/06/1988
Authorization expiration date
31/12/2025
IT number
02.04.5.
Domain
Human medicine
Field of application
Durchblutungsstörungen

Packaging details

Description (FR)
PENTOXI Mepha cpr ret 400 mg 20 pce
Description (DE)
PENTOXI Mepha Ret Tabl 400 mg 20 Stk
Market withdrawal
31/12/2025
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data